title: Concurrent coxibs and anti-platelet therapy unmasks aspirin-exacerbated respiratory disease.
authors.affiliation: Hospital La Paz Institute for Health Research (IdiPAZ), Madrid.
authors.forename: Irina
authors.initials: I
authors.lastname: Bobolea
authors.forename: Rosario
authors.initials: R
authors.lastname: Cabañas
authors.forename: Jesús
authors.initials: J
authors.lastname: Jurado-Palomo
authors.forename: Ana
authors.initials: A
authors.lastname: Fiandor
authors.forename: Santiago
authors.initials: S
authors.lastname: Quirce
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D050171:Dyslipidemias / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D009298:Nasal Polyps / Q000139:chemically induced; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012120:Respiration Disorders / Q000139:chemically induced* / Q000188:drug therapy*; D012852:Sinusitis / Q000139:chemically induced; D013147:Spirometry
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin